These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9488064)

  • 61. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?
    Brown GA; Busby JE; Wood CG; Pisters LL; Dinney CP; Swanson DA; Grossman HB; Pettaway CA; Munsell MF; Kamat AM; Matin SF
    BJU Int; 2006 Dec; 98(6):1176-80. PubMed ID: 17125474
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Genitourinary tumor following kidney transplantation: a multicenter study.
    Einollahi B; Simforoosh N; Lessan-Pezeshki M; Basiri A; Nafar M; Pour-Reza Gholi F; Firouzan A; Ahmadpour P; Makhdomi K; Ghafari A; Taghizadeh A; Tayebi Khosroshahi H
    Transplant Proc; 2009 Sep; 41(7):2848-9. PubMed ID: 19765454
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Laparoscopic nephroureterectomy for upper tract transitional cell carcinoma.
    McNeill SA; Tolley DA
    Arch Esp Urol; 2002; 55(6):595-601. PubMed ID: 12224158
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract.
    Park S; Hong B; Kim CS; Ahn H
    J Urol; 2004 Feb; 171(2 Pt 1):621-5. PubMed ID: 14713773
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transitional cell carcinoma in renal transplant recipients.
    Liao CH; Chueh SC; Lai MK; Chen J
    Transplant Proc; 2004 Sep; 36(7):2152-3. PubMed ID: 15518781
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Is there a role for FISH in the management and surveillance of patients with upper tract transitional-cell carcinoma?
    Chen AA; Grasso M
    J Endourol; 2008 Jun; 22(6):1371-4. PubMed ID: 18578665
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ploidy and Tn-antigen expression in the detection of transitional cell neoplasia in non-tumour-bearing patients.
    Pinnock CB; Roxby DJ; Ross JM; Pozza CH; Marshall VR
    Br J Urol; 1995 Apr; 75(4):461-9. PubMed ID: 7788257
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nephrogenic adenoma of the bladder in renal transplant and non-renal transplant patients: a review of 22 cases.
    Tse V; Khadra M; Eisinger D; Mitterdorfer A; Boulas J; Rogers J
    Urology; 1997 Nov; 50(5):690-6. PubMed ID: 9372876
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transitional cell carcinoma of the upper urinary tract: analysis of morphology and distribution for surgical management.
    Fujimoto H; Tobisu K; Mizutani T; Sakamoto M; Kakizoe T
    Jpn J Clin Oncol; 1993 Oct; 23(5):303-8. PubMed ID: 8230755
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transitional carcinoma of the upper urinary tract: a histological and cytopathological study.
    Highman WJ
    J Clin Pathol; 1986 Mar; 39(3):297-305. PubMed ID: 3958217
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Analgesic-associated nephropathy and transitional cell carcinoma of the urinary tract.
    Gonwa TA; Corbett WT; Schey HM; Buckalew VM
    Ann Intern Med; 1980 Aug; 93(2):249-52. PubMed ID: 7406375
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development of urologic de novo malignancies after renal transplantation.
    Hevia V; Gómez V; Díez Nicolás V; Alvarez S; Gómez Del Cañizo C; Galeano C; Gomis A; García-Sagredo JM; Marcen R; Burgos FJ
    Transplant Proc; 2014; 46(1):170-5. PubMed ID: 24507046
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Voided urine fluorescence in situ hybridization testing for upper tract urothelial carcinoma surveillance.
    Johannes JR; Nelson E; Bibbo M; Bagley DH
    J Urol; 2010 Sep; 184(3):879-82. PubMed ID: 20643443
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Endourologic treatment of transitional cell carcinoma of the upper urinary tract].
    Lancini V; Liatsikos EN; Bernardo NO; Dinlenc CZ; Kapoor R; Smith AD
    Minerva Urol Nefrol; 2000 Mar; 52(1):17-28. PubMed ID: 11517826
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Imperative indications for conservative management of upper tract transitional cell carcinoma.
    Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Elliott DS; Blute ML
    J Urol; 2007 Sep; 178(3 Pt 1):792-6; discussion 796-7. PubMed ID: 17632132
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Does paracetamol cause urothelial cancer or renal papillary necrosis?
    McCredie M; Stewart JH
    Nephron; 1988; 49(4):296-300. PubMed ID: 3412544
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology.
    Raman JD; Ng CK; Boorjian SA; Vaughan ED; Sosa RE; Scherr DS
    BJU Int; 2005 Nov; 96(7):1031-5. PubMed ID: 16225523
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Purse-string technique for laparoscopic excision of a bladder mucosal cuff in patients with transitional cell carcinoma of the upper urinary tract: initial report with intermediate follow-up.
    Shoma AM
    BJU Int; 2009 Nov; 104(10):1505-9. PubMed ID: 19426193
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Analgesic nephropathy and urothelial carcinoma.
    Handa SP
    Can Med Assoc J; 1979 Oct; 121(7):849-50. PubMed ID: 497970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.